1. Home
  2. CSL vs MDGL Comparison

CSL vs MDGL Comparison

Compare CSL & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$330.66

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$559.81

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSL
MDGL
Founded
1917
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
12.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CSL
MDGL
Price
$330.66
$559.81
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$386.67
$553.08
AVG Volume (30 Days)
454.8K
317.0K
Earning Date
02-03-2026
11-04-2025
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
17.56
N/A
Revenue
$5,015,100,000.00
$740,640,000.00
Revenue This Year
$1.01
$436.04
Revenue Next Year
$2.69
$53.17
P/E Ratio
$18.85
N/A
Revenue Growth
0.14
864.21
52 Week Low
$293.43
$265.00
52 Week High
$435.92
$605.00

Technical Indicators

Market Signals
Indicator
CSL
MDGL
Relative Strength Index (RSI) 58.53 54.32
Support Level $318.33 $546.20
Resistance Level $340.00 $589.67
Average True Range (ATR) 7.85 20.61
MACD 2.46 -6.67
Stochastic Oscillator 71.15 20.49

Price Performance

Historical Comparison
CSL
MDGL

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: